Literature DB >> 2832332

Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues.

D J Schol1, W J Mooi, A A van der Gugten, S S Wagenaar, J Hilgers.   

Abstract

Monoclonal antibody (MAb) 123C3 was raised against a membrane preparation of a small cell lung carcinoma (SCLC) specimen and its reactivity on normal tissues was tested. For the endocrine system, positive tissues included: pituitary and adrenal glands, thyrocytes and C-cells of the thyroid, the parathyroids, testis Leydig cells and pancreatic islets. In bronchioles and intestinal epithelium occasional cells, resembling Kultchitsky and enterochromaffin cells, were also positive. Epithelia like rete testis, mammary epithelium and gastric mucosa were positive in all or a significant proportion of cells. The positive cells in mammary epithelium and gastric mucosa were too numerous to represent the endocrine cells only. Neurons were usually negative or weakly positive. Their supportive cells such as glial, Schwann and ganglionic satellite cells were positive. Mesenchymal cell types, such as smooth muscle cells in most organs, cardiac muscle cells, the pia-arachnoid and ovarian stroma cells were positive, indicating that 123C3 reactivity is not confined to epithelial and neuron-supporting tissues. In Western blots of tumour specimens 123C3 recognized a 29 kDa band in reducing conditions, shifting to approximately 150 kDa in non-reducing conditions. Immunofluorescence on live tissue culture cells demonstrated presence of the antigen on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832332     DOI: 10.1002/ijc.2910410711

Source DB:  PubMed          Journal:  Int J Cancer Suppl        ISSN: 0898-6924


  10 in total

1.  Two monoclonal antibodies against small-cell lung cancer show existence of synergism in binding.

Authors:  S Saito; T Inoue; I Kawase; H Hara; Y Tanio; I Tachibana; S Hayashi; M Watanabe; M Matsunashi; T Osaki
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression.

Authors:  J A Reed; B Finnerty; A P Albino
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  Second primary lung cancer: importance of long term follow up.

Authors:  P C van Bodegom; S S Wagenaar; B Corrin; J P Baak; J Berkel; R G Vanderschueren
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

4.  Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3.

Authors:  H B Kwa; A H Verhoeven; J Storm; N van Zandwijk; W J Mooi; J Hilkens
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

5.  Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids.

Authors:  P Komminoth; J Roth; P M Lackie; D Bitter-Suermann; P U Heitz
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

6.  A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm.

Authors:  S P Bourne; K Patel; F Walsh; C J Popham; H B Coakham; J T Kemshead
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

7.  Immunohistochemical analysis of neural cell adhesion molecules. Differential expression in small round cell tumors of childhood and adolescence.

Authors:  P Garin-Chesa; E J Fellinger; A G Huvos; H R Beresford; M R Melamed; T J Triche; W J Rettig
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

8.  Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon.

Authors:  S P Langdon; G J Rabiasz; L Anderson; A A Ritchie; R J Fergusson; F G Hay; E P Miller; P Mullen; J Plumb; W R Miller
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

9.  Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.

Authors:  Yasin Şenbabaoğlu; Ron S Gejman; Andrew G Winer; Ming Liu; Eliezer M Van Allen; Guillermo de Velasco; Diana Miao; Irina Ostrovnaya; Esther Drill; Augustin Luna; Nils Weinhold; William Lee; Brandon J Manley; Danny N Khalil; Samuel D Kaffenberger; Yingbei Chen; Ludmila Danilova; Martin H Voss; Jonathan A Coleman; Paul Russo; Victor E Reuter; Timothy A Chan; Emily H Cheng; David A Scheinberg; Ming O Li; Toni K Choueiri; James J Hsieh; Chris Sander; A Ari Hakimi
Journal:  Genome Biol       Date:  2016-11-17       Impact factor: 13.583

10.  Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.

Authors:  H B Kwa; J Wesseling; A H Verhoeven; N van Zandwijk; J Hilkens
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.